SCP
MED icon

Seizert Capital Partners’s Medifast MED Stock Holding History

Seizert Capital Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,882
Closed -$4.16M – 214
2021
Q4 		$4.16M Buy
19,882
+483
+2% +$99.8K 0.19% 87
2021
Q3 		$3.74M Buy
19,399
+1,409
+8% +$346K 0.17% 94
2021
Q2 		$5.09M Buy
17,990
+5,398
+43% +$1.46M 0.24% 70
2021
Q1 		$2.67M Buy
12,592
+2,201
+21% +$527K 0.14% 97
2020
Q4 		$2.04M Buy
+10,391
New +$1.84M 0.12% 80
2019
Q3 		– Sell
-4,729
Closed -$607K – 215
2019
Q2 		$607K Sell
4,729
-208
-4% -$28.9K 0.03% 142
2019
Q1 		$630K Sell
4,937
-29
-0.6% -$3.68K 0.03% 145
2018
Q4 		$621K Sell
4,966
-33
-0.7% -$5.64K 0.03% 141
2018
Q3 		$1.11M Sell
4,999
-18,568
-79% -$3.76M 0.04% 137
2018
Q2 		$2.2M Hold
23,567
– – 0.08% 98
2018
Q1 		$2.2M Sell
23,567
-27,028
-53% -$2.02M 0.08% 98
2017
Q4 		$3.53M Sell
50,595
-26,755
-35% -$1.77M 0.13% 76
2017
Q3 		$4.59M Sell
77,350
-7,847
-9% -$390K 0.17% 70
2017
Q2 		$3.53M Buy
85,197
+1,442
+2% +$62.7K 0.13% 80
2017
Q1 		$3.72M Buy
+83,755
New +$3.61M 0.13% 72
2014
Q2 		– Sell
-49,117
Closed -$1.43M – 216
2014
Q1 		$1.43M Buy
49,117
+3,967
+9% +$106K 0.03% 116
2013
Q4 		$1.18M Buy
+45,150
New +$1.16M 0.03% 125

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Seizert Capital Partners's MED Position: Q1 2022 in Review

Seizert Capital Partners sold out of Medifast (MED) in Q1 2022, closing a stake of 19,882 shares — an estimated $4.16M sold.

Seizert Capital Partners first reported a position in MED in Q4 2013 and held it in 17 quarters. The position peaked at $5.09M in Q2 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Seizert Capital Partners reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Seizert Capital Partners sold 19,882 Medifast shares in Q1 2022, an estimated $4.16M.
  • Seizert Capital Partners first reported a position in Medifast in Q4 2013 and held it in 17 quarters.
  • Seizert Capital Partners's Medifast position peaked at $5.09M in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Seizert Capital Partners's 13F filing for Q1 2022, filed 3 May 2022.